Allosteric interactions among drug binding sites on calmodulin.
Felodipine is a fluorescent dihydropyridine Ca2+-antagonist. It binds to calmodulin in a Ca2+-dependent manner, and undergoes a fluorescence increase which allows us to monitor its interaction with calmodulin. Hydrophobic ligands including the calmodulin antagonist, R24571 and Ca2+ antagonists, prenylamine and diltiazem, bind to calmodulin and potentiate felodipine binding by as much as 20 fold. These studies suggest that allosteric interactions occur among different drug binding sites on calmodulin. Our results are discussed in terms of the mechanism of action of calmodulin.
D000495:Allosteric Site / Q000187:drug effects; D002118:Calcium / Q000037:antagonists & inhibitors; D002135:Calcium-Binding Proteins / Q000378:metabolism*; D002147:Calmodulin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D015736:Felodipine; D009543:Nifedipine / Q000031:analogs & derivatives / Q000378:metabolism*; D011485:Protein Binding; D011725:Pyridines / Q000378:metabolism*; D013050:Spectrometry, Fluorescence
D002135:Calcium-Binding Proteins; D002147:Calmodulin; D011725:Pyridines; D009543:Nifedipine; D015736:Felodipine; D002118:Calcium